Clinical Outcomes Following Treatment With SYSTANE® BALANCE

Clinical Evaluation Following Use of SYSTANE® BALANCE in Subjects With Lipid-Deficient Dry Eye

The purpose of this study is to evaluate the clinical effectiveness of SYSTANE® BALANCE compared to REFRESH OPTIVE® Advanced in subjects with lipid-deficient dry eye.

Inclusion Criteria:

• Willing and able to attend all study visits;
• Must sign an informed consent form;
• Best-corrected visual acuity (BCVA) of 55 letters or better in each eye as assessed using an early treatment diabetic retinopathy study (ETDRS) chart;
• Willing to take study products as directed for entire study;
• Other protocol-specified inclusion criteria may apply.

Exclusion Criteria:

• Women of childbearing potential who are pregnant, plan to become pregnant during the study, breast feeding, or not using adequate birth control methods;
• Contact lens use within 30 days prior to Screening Visit, or unwilling to avoid contact lens use during the course of the study;
• Use of medication excluded by the protocol;
• Diseases, illnesses, infections, or ocular abnormalities excluded by the protocol;
• Ocular surgeries or procedures excluded by the protocol;
• Other protocol-specified exclusion criteria may apply.